ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 145 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2023. The put-call ratio across all filers is 1.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $26,631 | +40.3% | 1,111 | -0.7% | 0.00% | 0.0% |
| Q4 2022 | $18,978 | -20.9% | 1,119 | -31.1% | 0.00% | 0.0% |
| Q3 2022 | $24,000 | -35.1% | 1,624 | -30.8% | 0.00% | 0.0% |
| Q2 2022 | $37,000 | +8.8% | 2,348 | +84.3% | 0.00% | 0.0% |
| Q1 2022 | $34,000 | -32.0% | 1,274 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $50,000 | -43.2% | 1,274 | -30.5% | 0.00% | -60.0% |
| Q3 2021 | $88,000 | +114.6% | 1,834 | +52.2% | 0.01% | +150.0% |
| Q2 2021 | $41,000 | – | 1,205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DFPG INVESTMENTS, LLC | 183,803 | $9,359,000 | 5.00% |
| DAFNA Capital Management LLC | 229,652 | $9,852,000 | 3.20% |
| HealthCor Management, L.P. | 1,594,452 | $68,402,000 | 2.74% |
| Capital Impact Advisors, LLC | 110,000 | $4,719,000 | 1.40% |
| Cormorant Asset Management, LP | 700,000 | $30,030,000 | 1.16% |
| ARK Investment Management | 2,495,842 | $107,072,000 | 0.64% |
| Millrace Asset Group, Inc. | 18,087 | $776,000 | 0.63% |
| COOPER CREEK PARTNERS MANAGEMENT LLC | 50,532 | $2,168,000 | 0.54% |
| Endurant Capital Management LP | 34,485 | $1,479,000 | 0.44% |
| HealthCor Management, L.P. | 200,000 | $8,580,000 | 0.34% |